BioSpace News Archive

Drug Development

First patient dosed in IPH5201 Phase I clinical trial in advanced solid tumors

Anti-CD39 monoclonal antibody, IPH5201, advances to first-in-human clinical trial; first molecule from Innate/AstraZeneca expanded collaboration progressing to the clinic

March 10, 2020
·
6 min read
Business

Innate Pharma Reports Full Year 2019 Financial Results and Business Update

Innate Pharma SA reported its consolidated financial results for the year ending December 31, 2019. The consolidated financial statements are attached to this press release..

March 10, 2020
·
32 min read
German Company Pharmact AG Develops a Point-of-Care Rapid Test for the Detection of the Coronavirus (SARS-CoV-2)

The fear of the Coronavirus is currently spreading throughout Germany and the world.

March 10, 2020
·
4 min read
Deals

Nordic Nanovector ASA - Financial calendar - March 10, 2020

Financial calendar for Nordic Nanovector ASA

March 10, 2020
·
1 min read
Deals

Kirin Holdings Provides Update to Capital Markets

Kirin Holdings Co., Ltd. held an Investor Day in Tokyo on March 3 to facilitate mutual understanding with the capital markets on Kirin’s long-term sustainable growth.

March 10, 2020
·
14 min read
Carag First-ever Septal Occluder With Bioresorbable, Metal-free Framework Available to Patients Through New European Registry

CARAG AG announced the successful implantation of the first-ever transcatheter septal occluder with bioresorbable, metal-free framework, as part of a new international post-market registry.

March 10, 2020
·
3 min read
Business

Eyevensys Announces Executive Leadership Team Expansion

Eyevensys announced the expansion of its leadership team with the appointment of Gerald Cagle as the Board’s Chairman, Francine Behar-Cohen to Chief Innovation Officer and Thierry Bordet as the Chief Scientific Officer.

March 10, 2020
·
4 min read
Business

POINT Biopharma and SCINTOMICS Announce License Agreement-POINT Biopharma acquires next generation prostate cancer radiotherapeutic-

POINT Biopharma Inc. announced that it has entered into an agreement with SCINTOMICS GmbH for the exclusive use and development of a family of more than seventy patented next generation PSMA radioligands for targeted radiotherapy of prostate cancer.

March 10, 2020
·
2 min read
Drug Development

First Liver Cancer Patient Dosed in the MIV-818 Phase Ib Study

Medivir AB announced that the first patient with advanced liver cancer has been dosed in the phase Ib study of MIV-818.

March 10, 2020
·
3 min read
Drug Development

Novavax Awarded Funding from CEPI for COVID-19 Vaccine Development

Novavax, Inc. (NASDAQ: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced that the Coalition for Epidemic Preparedness (CEPI) awarded an initial funding of $4 million to support Novavax’ efforts to develop a COVID-19 vaccine

March 10, 2020
·
5 min read